EFFECT OF TOBRAMYCIN INHALATION SOLUTION ON MORTALITY IN SUBGROUPS OF PATIENTS WITH CYSTIC FIBROSIS

被引：0
|
作者：
Latremouille-Viau, D. [1 ]
Sawicki, G. S. [2 ]
Zhang, J. [3 ]
von Wartburg, M. [1 ]
Signorovitch, J. [1 ]
Wu, E. Q. [1 ]
Shi, L. [4 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Tulane Univ, New Orleans, LA 70118 USA
来源：
PEDIATRIC PULMONOLOGY | 2011年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：346 / 346
页数：1
相关论文
共 50 条
  • [41] Tobramycin inhalation powder (TOBI Podhaler®) for the treatment of lung infection in patients with cystic fibrosis
    Vazquez-Espinosa, E.
    Marcos, C.
    Alonso, T.
    Giron, R. M.
    Gomez-Punter, R. M.
    Garcia-Castillo, E.
    Zamora, E.
    Cisneros, C.
    Garcia, J.
    Valenzuela, C.
    Ancochea, J.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (01) : 9 - 17
  • [42] Pharmacodynamics of tobramycin in patients with cystic fibrosis
    Mouton, JW
    Jacobs, N
    Tiddens, H
    Horrevorts, AM
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (02) : 123 - 127
  • [43] POST-INHALATION COUGH IN CYSTIC FIBROSIS PATIENTS TREATED WITH TOBRAMYCIN POWDER FOR INHALATION (TIP™): ETOILES STUDY
    Virella-Lowell, I
    Sommerwerck, U.
    Angyalosi, G.
    Viegas, A. S.
    Vandemeulebroecke, M.
    Debonnett, L.
    [J]. PEDIATRIC PULMONOLOGY, 2014, 49 : 362 - 363
  • [44] The Use of High Resolution Computerized Tomography (HRCT) of the Chest in Evaluating the Effect of Tobramycin Solution for Inhalation in Cystic Fibrosis Lung Disease
    Nasr, Samya Z.
    Sakmar, Ermelinda
    Christodoulou, Emmanuel
    Eckhardt, Boris P.
    Streetman, Daniel S.
    Strouse, Peter J.
    [J]. PEDIATRIC PULMONOLOGY, 2010, 45 (05) : 440 - 449
  • [45] Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system
    Geller, DE
    Rosenfeld, M
    Waltz, DA
    Wilmott, RW
    [J]. CHEST, 2003, 123 (01) : 28 - 36
  • [46] Concept of antibiotic inhalation therapy in cystic fibrosis - On a dosage form of tobramycin
    Sermut-Gaudelus, I
    Hubert, D
    Turck, D
    [J]. ARCHIVES DE PEDIATRIE, 2001, 8 : 884S - 893S
  • [47] Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
    Nikolaizik, WH
    Trociewicz, K
    Ratjen, F
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (01) : 122 - 126
  • [48] Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and cough
    Meerburg, Jennifer J.
    Albasri, Mehdi
    van der Wiel, Els C.
    Andrinopoulou, Eleni-Rosalina
    van der Eerden, Menno M.
    Majoor, Christof J.
    Arets, Hubertus G. M.
    Heijerman, Harry G. M.
    Tiddens, Harm A. W. M.
    [J]. PEDIATRIC PULMONOLOGY, 2019, 54 (11) : 1794 - 1800
  • [49] EVALUATION OF TOLERABILITY OF TOBRAMYCIN INHALATION POWDER IN AN ADULT CYSTIC FIBROSIS POPULATION
    Stephen, M. J.
    Hoag, J. B.
    Thakur, T.
    [J]. PEDIATRIC PULMONOLOGY, 2015, 50 : 329 - 330
  • [50] TOBRAMYCIN POWDER FOR INHALATION FOR THE TREATMENT OF CYSTIC FIBROSIS: ANALYSIS OF THE RAMQ DATA
    Lachaine, J.
    Lapierre, M. E.
    Beauchemin, C.
    Balp, M. M.
    Calado, F.
    Debonnett, L.
    Desforges, J.
    Sagkriotis, A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A361 - A361
12345